All Pharma articles – Page 42
-
News
Mental health trust may scan for weapons and drugs
Airport style scanners for weapons and drugs could be installed in mental health wards, a leaked email seen by HSJ has revealed.
-
News
Sir Michael Rawlins reappointed NICE chair
Sir Michael Rawlins has been reappointed as chair of the National Institute for Health and Clinical Excellence after a special exemption to allow him to extend his tenure.
-
News
DH consults on speeding up drug decisions
Health minister Lord Darzi has launched a consultation designed to speed up access to new drugs and reduce variation between primary care trust areas.
-
News
NICE clarifies breast cancer guidance
The National Institute for Health and Clinical Excellence has re-worked its breast cancer guidelines in a bid to standardise care across the country.
-
HSJ KnowledgeWhy NICE values some patients' lives more
Mike Richards’ review of what to do about top-ups seems to reaffirm the line that the NHS should not subsidise private consumption of healthcare.
-
News
NICE lacks GP input says NHS Alliance
The NHS Alliance has given muted approval to Department of Health proposals to change the quality and outcomes framework GP bonus scheme.
-
News
NHS links to pharmaceutical industry raise suspicions, RCP warns
The medical profession needs to distance itself from the pharmaceutical industry to restore public confidence in the NHS, doctors have warned.
-
News
Government boosts flu pandemic drug stockpile
The government has awarded contracts to double supplies of antiviral drugs to treat pandemic flu.
-
News
Edwina Hart steals march on NICE with kidney drug decision
Welsh health minister Edwina Hart has angered some local health boards - and stepped further into NHS decision making - by ordering managers to pay for four unapproved drugs for advanced kidney cancer.
-
News
PCTs failing to involve public in drug decisions
Primary care trusts are failing to effectively involve the public in decisions over drugs not approved by the National Institute for Health and Clinical Excellence, according to a Picker Institute review.
-
News
NHS drug shortage looms as pound falls
The NHS could face a shortage of drugs because the weak pound means speculators are targeting UK pharmaceutical supplies for export to more lucrative markets.Data obtained by HSJ shows there has also been a dramatic slowdown in imports of cut-price branded drugs into the UK.
-
News
DH publishes reactions to pharmacy consultation
An analysis of responses to the Department of Health's proposals to improve pharmacy services has been published.
-
News
NICE backs changes to end of life drugs policy
The National Institute for Health and Clinical Excellence is to proceed with controversial plans to broaden access to drugs for terminally ill people.
-
News
New guidance on pharmaceutical needs assessments
NHS Employers has launched guidance for primary care trusts on how to develop pharmaceutical needs assessments in line with world class commissioning.
-
News
End of life drugs move raises budget concerns
The National Institute for Health and Clinical Excellence is to proceed with controversial plans to broaden access to drugs for the terminally ill in the face of serious concerns from health managers.
-
News
'Cartel' pharmaceutical company pays £1m settlement
A pharmaceutical company accused of “anti-competitive cartel conduct” is to pay more than £1m in an out of court settlement.'
-
News
End of life drugs set to put financial pressure on PCTs
PCTs could face significant financial pressures as a result of proposals to make more drugs available to patients at the end of life, the NHS Confederation is warning.
-
News
Comply with NICE or pay, Care Quality Commission tells trusts
Healthcare providers could be shut down for failing to comply with National Institute for Health and Clinical Excellence guidance under plans to make adherence a requirement of the Care Quality Commission's registration scheme.
-
HSJ Knowledge
Pharmacy's perfect prescription for community health
Local pharmacies are more than just a purveyor of pills. They have the potential to improve the health of communities if commissioners have the courage to invest in them
-
News
Pharmaceutical industry tactics could be blocking generic drugs
The European Commission has uncovered a 'tool box' of pharmaceutical company strategies that may be delaying availability of cheaper generic alternatives to costly patented medicines.